A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activity
Biochimie · 2024
DOI: 10.1016/j.biochi.2023.09.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimie, 2024. Verfasst von Anika Kleine und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, G…. Hauptthemen laut MEDLINE: UDP Xylose-Protein Xylosyltransferase, Pentosyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ruhr-Universität Bochum.
Abstract (Originalsprache)
Xylosyltransferase-I and -II (XT-I, -II) possess a central role during the glycosylation of proteoglycans (PGs). They catalyze the formation of an O-glycosidic bond between the xylosyl residue of uridinediphosphate-xylose and the core protein of a PG. Thereafter, three following glycosyltransferases lead to the generation of a tetrasaccharide linker, which connects the PG core protein to the respective glycosaminoglycan. The selective quantification of XT-I and XT-II activity is of biological and clinical interest due to their association with fibrotic processes and skeletal dysplasia. There is no assay available to date that simultaneously determines the activity of the two XT isoforms. Although an XT-I selective UPLC MS/MS-based assay was published by Fischer et al., in 2021, the determination of XT-II activity can only be performed simultaneously by the improved assay presented here. To establish the assay, two synthetic peptides, selectively xylosylated by the respective isoform, were identified and the associated measurement parameters for the mass spectrometer were optimized. In addition, the quantitative range of the xylosylated peptides were validated, and the incubation time of the enzyme reaction was optimized for cell culture samples and human sera. The specific enzyme kinetics (KM and Vmax) of the respective XT isoform for the two peptides were also determined. Subsequently, a mathematical model was developed, allowing the simultaneous determination of XT-I and XT-II activity from the chromatographic results. Summarized, a mass spectrometric method suitable for the simultaneous analysis of XT-I and XT-II activity in cell culture lysates, supernatants and human sera was successfully developed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Georgstraße 11, 32545, Bad Oeynhausen, Germany. Electronic address: ank…
- Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Georgstraße 11, 32545, Bad Oeynhausen, Germany.
Förderung
- Ruhr-Universität Bochum
Zitieren
APA
Kleine, A., Kühle, M., Kuhn, J., Ly, T. D., Schmidt, V., Faust-Hinse, I., Knabbe, C., & Fischer, B. (2024). A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activity. Biochimie. https://doi.org/10.1016/j.biochi.2023.09.008
Vancouver
Kleine A, Kühle M, Kuhn J, Ly TD, Schmidt V, Faust-Hinse I, et al. A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activity. Biochimie. 2024. doi:10.1016/j.biochi.2023.09.008
BibTeX
@article{Kleine2024,
author = {Kleine, Anika and Kühle, Matthias and Kuhn, Joachim and Ly, Thanh-Diep and Schmidt, Vanessa and Faust-Hinse, Isabel and Knabbe, Cornelius and Fischer, Bastian},
title = {A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activity},
journal = {Biochimie},
year = {2024},
doi = {10.1016/j.biochi.2023.09.008}
}
EUVIMED